HealthAI imageDr Reddy's Partners with Gilead for Annual HIV Prevention Drug
Dr Reddy's Laboratories has signed an agreement with Gilead Sciences to market lenacapavir, a once-yearly HIV prevention drug. This collaboration aims to enhance access to innovative HIV treatments, offering patients a convenient annual dosing option to prevent HIV infection effectively.
News 18·




